Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -0 | 0 | 0 | -1 | -1↓87.7% |
| Operating Income | -3 | -16↓410.9% | -33↓101.8% | -67↓105.9% | -89↓32.7% |
| Net Income | -5 | -16↓206.1% | -31↓91.9% | -60↓93.8% | -81↓33.4% |
| EBITDA | -5 | -16↓205.1% | -32↓100.0% | -60↓85.3% | -80↓32.9% |
| EPS Diluted | -0.41 | -1.26↓207.3% | -1.42↓12.7% | -2.74↓93.0% | -2.10↑23.4% |